A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus

Human immunodeficiency virus type 1 circulates in vivo as a mixture of heterologous populations (quasispecies). We previously analyzed the quasispecies of the third hypervariable region (V3) in the viral envelope glycoprotein gp120 in an infected individual and found that the species with a basic amino acid substitution (lysine for aspartic acid) at a particular position evolved and became a distinct population within a short period, followed by progression to the typical immunodeficiency stage (S. Oka et al., AIDS Res. Hum. Retroviruses 10:271-277, 1994). In the present study, we examined the biological significance of this amino acid substitution by constructing recombinant viruses with specific point mutations and comparing their replication capabilities in different cell types. The results demonstrated that the single basic amino acid substitution was sufficient to render a virus fully capable of replicating in human T-cell lines under certain conditions. With an acidic amino acid at the position, the virus grew much less fast or did not grow at all in the T-cell lines. Viral neutralization assay and peptide enzyme-linked immunosorbent assays further showed that this amino acid substitution resulted in different recognition by several of the serum specimens from human immunodeficiency virus type 1-infected individuals and thus could alter the antigenic structure. An additional finding worthy of note was that at the terminal stage, the proviral sequences of peripheral blood mononuclear cells and the viral isolates from them were without exception of the late type with the basic amino acid substitution, whereas the early sequence without the substitution was retained as a major subset in the spleen. These results support the notion that basic amino acid substitutions in V3 are a strong predictor of virus tropism and may be relevant to disease progression.

[1]  安井 明 Dna repair enzyme , 1995 .

[2]  P. Earl,et al.  Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities , 1994, Journal of virology.

[3]  C. Cheng‐Mayer,et al.  Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization , 1994, Journal of virology.

[4]  S. Oka,et al.  Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. , 1994, AIDS research and human retroviruses.

[5]  B. Margolin,et al.  V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.

[6]  H. Gayle,et al.  Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.

[7]  N. Haigwood,et al.  Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals , 1993, Journal of virology.

[8]  J. Moore,et al.  Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans , 1993, Journal of virology.

[9]  B. Chesebro,et al.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.

[10]  A. Saah,et al.  Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Cheng‐Mayer,et al.  Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[13]  G. Shaw,et al.  Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo , 1992, Journal of virology.

[14]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[15]  C. Kuiken,et al.  Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. , 1991, Virology.

[16]  P. Simmonds,et al.  Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.

[17]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[18]  S. Matsushita,et al.  Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. , 1990, Journal of immunology.

[19]  J. Davide,et al.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.

[20]  J. Berzofsky,et al.  An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself , 1990, The Journal of experimental medicine.

[21]  J. Berzofsky,et al.  Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein , 1989, The Journal of experimental medicine.

[22]  L. Pearl,et al.  Characterization of HIV‐1 neutralization escape mutants , 1989, AIDS.

[23]  Andreas Meyerhans,et al.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.

[24]  J. Goudsmit,et al.  ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY , 1989, The Lancet.

[25]  J. Holland,et al.  Extreme heterogeneity in populations of vesicular stomatitis virus , 1989, Journal of virology.

[26]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[27]  L. Loeb,et al.  Fidelity of HIV-1 reverse transcriptase. , 1988, Science.

[28]  K Bebenek,et al.  The accuracy of reverse transcriptase from HIV-1. , 1988, Science.

[29]  P. Palese,et al.  Determination of the mutation rate of a retrovirus , 1988, Journal of virology.

[30]  H. Temin,et al.  Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication , 1988, Journal of virology.

[31]  S. Matsushita,et al.  Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope , 1988, Journal of virology.

[32]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[33]  M. Hamaguchi,et al.  Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus. , 1988, Virology.

[34]  R. Lerner,et al.  Chemistry of antibody binding to a protein. , 1987, Science.

[35]  J Sninsky,et al.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. , 1989, Journal of acquired immune deficiency syndromes.

[36]  E. Domingo,et al.  The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. , 1985, Gene.

[37]  J. Berzofsky,et al.  The antigenic structure of proteins: a reappraisal. , 1984, Annual review of immunology.